Assertio Holdings | DEPO - Pre Tax Profit

Stock Price
19.39
Daily Change
-0.14 -0.72%
Monthly
64.74%
Yearly
86.88%
Q1 Forecast
18.01

Assertio Holdings reported $-2.88M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Assertio Holdings USD -2.88M 648K Sep/2024
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Daiichi Sankyo JPY 106.73B 48.96B Dec/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Merck USD 6.74B 22M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Omeros USD -65.12M 21.27M Jun/2024
Pfizer USD 3.33B 290M Sep/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025